October 2025 in “Journal of Bahria University Medical and Dental College” Free testosterone is the most common hormone marker in PCOS, and age affects DHEAS levels.
September 2025 in “Archives of Dermatological Research” Basal cell carcinoma is more common than squamous cell carcinoma on the scalp, especially along the part line.
August 2025 in “BMC Research Notes” iPSC lines from different tissues share a common miRNA profile, supporting their pluripotent nature.
August 2025 in “Brazilian Journal of Hair Health” Hair-related body dysmorphic disorder is common in hair loss patients and needs early recognition for proper treatment.
August 2025 in “JURNAL PEMBELAJARAN DAN BIOLOGI NUKLEUS” Alopecia in bats is more common in urban areas due to habitat conditions.
Dual TCR Treg cells are common in mouse tissues and vary by location.
June 2025 in “Academic Medical Journal” Vitiligo treatments are improving but relapses are common.
June 2025 in “International Journal of Science and Research (IJSR)” Low iron and vitamin D are common in young females with hair loss.
June 2025 in “Annals of the Rheumatic Diseases” Brain fog in lupus is common, worrying, and often not treated properly.
Scalp involvement in primary cutaneous lymphomas is common and can be aggressive, requiring careful attention.
May 2025 in “InnovAiT Education and inspiration for general practice” Male pattern hair loss is common, affects mental health, and can be treated with medication or hair transplants.
April 2025 in “Scholars International Journal of Anatomy and Physiology” Straight-lined hairlines are most common among Etche people.
February 2025 in “Journal of Cosmetic Dermatology” Ferritin and vitamin B12 deficiencies are common causes of hair loss in women aged 18-45.
Hair restoration surgery is becoming more common as male pattern baldness increases with age.
January 2025 in “International Journal of Dermatology Sciences” Androgenetic alopecia is the most common type of non-scarring hair loss, especially in young males, and early diagnosis and treatment are important.
January 2025 in “Lume (Universidade Federal do Rio Grande do Sul)” Hair loss was the most common skin issue among healthcare workers with COVID-19.
January 2025 in “Directory of Open access Books (OAPEN Foundation)” Recent advances improve understanding and treatment of common skin diseases.
January 2025 in “International Journal of Trichology” Pattern hair loss is the most common type of alopecia.
January 2025 in “International Journal of Dermatology Sciences” Nail changes in alopecia areata are common and may indicate severity and genetic risk.
December 2024 in “Media Dermato Venereologica Indonesiana” Acne vulgaris was the most common skin disorder overall.
Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.
December 2024 in “Research Journal of Pharmaceutical Dosage Forms and Technology” The hair oil may effectively treat common hair problems with fewer side effects.
December 2024 in “PLoS ONE” Alopecia in gray bats is most common and severe during lactation, likely due to stress and nutrition.
October 2024 in “Eurasian Journal of Medicine” Hashimoto’s thyroiditis is more common in girls, often after puberty, and can cause neck swelling, fatigue, and hair loss.
October 2024 in “International Journal of Research in Dermatology” Fungal infections are the most common skin issue in the region.
September 2024 in “Brazilian Journal of Health Review” Female pattern hair loss is common and affects quality of life, but more research is needed for better treatments.
September 2024 in “Journal of Parasite Science” Dermatophytosis in cats was most common in young, male Persian cats, with symptoms like hair loss and crusts.
July 2024 in “Brazilian Journal of Clinical Medicine and Review” Hair loss after bariatric surgery is common due to nutrient deficiencies and rapid weight loss.
July 2024 in “LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)” Adipose tissue and eccrine gland displacement are common in certain alopecias but don't help differentiate between them.
Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.